Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG AAPL NFLX AMZN BIIB IBB WYNN TSLA ALXN CELG JAZZ ILMN CHTR AMGN COST FFIV SSYS GMCR Z
Nyse: V PXD ACT IBM UNP IVV LNKD MCK SPG LMT GS CMI MMM FDX TWC AGN CXO BA CVX XEC
New Highs: CLR AGN CXO KMB HP EQT CAT VNO SLB SRE NEE RRC EMN HES PEP DOV DTE WLL COP FANG

The Hot Industries

Independent Oil & Gas 5
Oil & Gas Drilling & Exploration 3
Diversified Machinery 2

The Hot Sectors

Basic Materials 11
Utilities 3
Industrial Goods 2

JNJ Stock Chart


JNJ
Analyze

Sector:

Healthcare
Daily

Industry:

Drug Manufacturers - Major
Weekly

Employees:

128,100
Monthly

Website:

http://www.jnj.com

JNJ Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

favicon

Dow 30 Stock Roundup: JNJ Beats, JPM Disappoints

17 Apr 2014, 7:46 amThe Dow notched up substantial gains during a holiday shortened week, boosted by several positive factors.
favicon

Will This Price Target Increase Help Johnson & Johnson (JNJ) Stock Today?

16 Apr 2014, 8:18 amNEW YORK (TheStreet) -- Leerink increased its price target on Johnson & Johnson  to $110, increased its estimates and set an "outperform" rating. The firm cited solid pharma momentum as the reason for the increase. The stock was flat at $99.24 at 9:52 a.m. on Wednesday. Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks ...
favicon

Jim Cramer: Why Johnson & Johnson (JNJ) and Coca-Cola (KO) Reported Surprising Results

15 Apr 2014, 10:18 amNEW YORK (TheStreet) -- TheStreet's Jim Cramer adds Johnson & Johnson  and Coca-Cola  to the list of big-cap companies that have reported surprising earnings recently. The stocks join Alcoa , Citigroup  and Wells Fargo . Johnson & Johnson had a strong pharma number of +10, or +12 before currency translation. Cramer was "blown away" by Coca-Cola's ability to turn on the marketing dollars and turn ...
favicon

Why Johnson & Johnson (JNJ) Stock Is Up Today

15 Apr 2014, 8:23 amNEW YORK (TheStreet) -- Johnson & Johnson  stock is gaining on Tuesday after the company reported first-quarter results and as it increased its full-year EPS targets.  By midmorning, shares had added 1.8% to $98.89.  Over the three months to March, the company reported earnings of $1.54 a share and revenue of $18.11 billion. Analysts surveyed by Thomson Reuters anticipated net income of $1.48 a ...
favicon

Will This Downgrade Hurt Johnson & Johnson (JNJ) Today?

14 Apr 2014, 7:38 amNEW YORK (TheStreet) -- Johnson & Johnson  has been downgraded to "hold" from "buy" with an $105 price target, Jefferies said Monday. The firm said though the company still has strong fundamentals, its current valuation is too high.  Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the ...
favicon

Analysts' Actions: JNJ MDT MSFT MA V

14 Apr 2014, 6:30 amHere are today's top research calls.
favicon

Cramer: Johnson & Johnson (JNJ) Deal Will Lead to Huge Buyback

1 Apr 2014, 9:19 amNEW YORK (TheStreet) -- TheStreet's Jim Cramer says Johnson & Johnson's deal to sell its Ortho-Clinical Diagnostics business to The Carlyle Group for $4 billion will lead to a buyback of "a huge amount of stock." Cramer says Johnson & Johnson CEO Alex Gorsky set expectations very low for the quarter and this deal was done perfectly so that the company can announce in conjunction with its ...
favicon

Weekly 52-Week Highs Highlight: MAR, JNJ, HAL, BHI

31 Mar 2014, 8:55 amAccording to GuruFocus list of 52-week highs; Marriott International Inc., Johnson & Johnson, Halliburton Company and Baker Hughes Inc.
favicon

Why Johnson & Johnson (JNJ) Stock May Move Higher On Monday

31 Mar 2014, 7:33 amNEW YORK (TheStreet) -- Shares of Johnson & Johnson may advance today after the Wall Street Journal reported this morning that the company had accepted Carlyle Group's bid to acquire its ortho-clinical diagnostics business for nearly $4 billion. The shares are up 0.37% to 97.80 in premarket trade. The ortho-clinical diagnostics business provides in vitro diagnostic products, transfusion donor ...
favicon

One Put, One Call Option To Know About for Johnson & Johnson

24 Mar 2014, 10:30 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the June expiration for JNJ.